-
1
-
-
59649126055
-
-
Int. Patent WO2003011837
-
Fraley, M. E.; Peckham, J. P.; Arrington, K. L.; Hoffman, W. F.; Hartman, G. D. Int. Patent WO2003011837, 2003.
-
(2003)
-
-
Fraley, M.E.1
Peckham, J.P.2
Arrington, K.L.3
Hoffman, W.F.4
Hartman, G.D.5
-
2
-
-
59649119284
-
-
Int. Patent WO2004005282
-
Furet, P.; Imbach, P.; Ramsey, T. M.; Schlapbach, A.; Scholz, D.; Caravatti, G. Int. Patent WO2004005282, 2004.
-
(2004)
-
-
Furet, P.1
Imbach, P.2
Ramsey, T.M.3
Schlapbach, A.4
Scholz, D.5
Caravatti, G.6
-
4
-
-
59649107330
-
-
Adams, J. L.; Faitg, Thomas, H.; Ralph, J. M.; Silva, D. J. Int. Patent WO2007024843, 2007.
-
Adams, J. L.; Faitg, Thomas, H.; Ralph, J. M.; Silva, D. J. Int. Patent WO2007024843, 2007.
-
-
-
-
5
-
-
59649094409
-
-
Int. Patent WO2001030154
-
Rheinheimer, J.; Eicken, K.; Rose, I.; Grote, T.; Ammermann, E.; Speakman, J. -B.; Strathmann, S.; Lorenz, G. Int. Patent WO2001030154, 2001.
-
(2001)
-
-
Rheinheimer, J.1
Eicken, K.2
Rose, I.3
Grote, T.4
Ammermann, E.5
Speakman, J.-B.6
Strathmann, S.7
Lorenz, G.8
-
8
-
-
0021919799
-
-
Bailey D.M., Hansen P.E., Hlavac A.G., Baizman E.R., Pearl J., DeFelice A.F., and Feigenson M.E. J. Med. Chem. 28 (1985) 256
-
(1985)
J. Med. Chem.
, vol.28
, pp. 256
-
-
Bailey, D.M.1
Hansen, P.E.2
Hlavac, A.G.3
Baizman, E.R.4
Pearl, J.5
DeFelice, A.F.6
Feigenson, M.E.7
-
10
-
-
59649120719
-
-
note
-
Interestingly, reaction of the 1-H-N-pyrazole with isocyanates or acyl chlorides afforded the beta isomer preferentially, in a 10:1 ratio or greater.
-
-
-
-
11
-
-
59649127196
-
-
note
-
HPLC analysis of the crude reaction mixture showed a β-to-α ratio of 11:1.
-
-
-
-
14
-
-
0142217504
-
-
Johns B.A., Gudmundsson K.S., Turner E.M., Allen S.H., Jung D.K., Sexton C.J., Boyd F.L., and Peel M.R. Tetrahedron 59 (2003) 9001
-
(2003)
Tetrahedron
, vol.59
, pp. 9001
-
-
Johns, B.A.1
Gudmundsson, K.S.2
Turner, E.M.3
Allen, S.H.4
Jung, D.K.5
Sexton, C.J.6
Boyd, F.L.7
Peel, M.R.8
-
15
-
-
27144513812
-
-
Stevens K.L., Jung D.K., Alberti M.J., Badiang J.G., Peckham G.E., Veal J.M., Cheung M., Harris P.A., Chamberlain S.D., and Peel M.R. Org. Lett. 7 (2005) 4753
-
(2005)
Org. Lett.
, vol.7
, pp. 4753
-
-
Stevens, K.L.1
Jung, D.K.2
Alberti, M.J.3
Badiang, J.G.4
Peckham, G.E.5
Veal, J.M.6
Cheung, M.7
Harris, P.A.8
Chamberlain, S.D.9
Peel, M.R.10
-
16
-
-
59649101950
-
-
note
-
Compound 17 was also prepared from 9 in similar overall yield using a longer synthetic sequence based on the 4-iodo pyrazole intermediate shown below:{A figure is presented}.
-
-
-
-
17
-
-
4444288154
-
-
Tavares F.X., Boucheron J.A., Dickerson S.H., Griffin R.J., Preugschat F., Thomson S.A., Wang T.Y., and Zhou H.-Q.J. J. Med. Chem. 47 (2004) 4716
-
(2004)
J. Med. Chem.
, vol.47
, pp. 4716
-
-
Tavares, F.X.1
Boucheron, J.A.2
Dickerson, S.H.3
Griffin, R.J.4
Preugschat, F.5
Thomson, S.A.6
Wang, T.Y.7
Zhou, H.-Q.J.8
-
18
-
-
59649098338
-
-
note
-
The enaminone was also prepared by reaction of the arylmethylketone with DMF-DMA as the solvent, but the yield was lower.
-
-
-
-
19
-
-
59649129036
-
-
note
-
Guanidine 19 was prepared by treating 3-(4-methyl-piperazin-1-yl)-aniline with 1,3-bis(tert-butoxy-carbonyl)guanidine, followed by deprotection with 12 N HCl.
-
-
-
|